Zhang_2021_J.Control.Release_329_1117

Reference

Title : Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds - Zhang_2021_J.Control.Release_329_1117
Author(s) : Zhang Y , He J , Shen L , Wang T , Yang J , Li Y , Wang Y , Quan D
Ref : J Control Release , 329 :1117 , 2021
Abstract :

Effective intracerebral delivery acetylcholinesterase (AChE) reactivator is key for the acute organophosphorus (OPs) poison treatment. However, the blood-brain barrier (BBB) restricts the transport of these drugs from blood into the brain. Herein, we developed transferrin receptor (TfR) aptamer-functionalized liposomes (Apt-LP) that could deliver AChE reactivator (obidoxime) across the BBB to act against paraoxon (POX) poisoning. The aptamer had strong affinity for TfR and was modified with 3'-inverted deoxythymidine (dT) to improve serum stability. The uptake of Apt-LP by bEnd.3 cells was significantly higher than that of non-targeting liposomes. The ability of Apt-LP to penetrate intact BBB was confirmed in in vitro BBB mice model and in vivo biodistribution studies. Treatment of POX-poisoned mice with Apt-LP-LuH-6 reactivated 18% of the brain AChE activity and prevented brain damage to some extent. Taken together, these results showed that Apt-LP may be used as a promising brain-targeted drug delivery system against OPs toxicity.

PubMedSearch : Zhang_2021_J.Control.Release_329_1117
PubMedID: 33096123

Related information

Citations formats

Zhang Y, He J, Shen L, Wang T, Yang J, Li Y, Wang Y, Quan D (2021)
Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds
J Control Release 329 :1117

Zhang Y, He J, Shen L, Wang T, Yang J, Li Y, Wang Y, Quan D (2021)
J Control Release 329 :1117